USANA Health Sciences (USNA) Misses Q3 EPS by 71c, provides guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall St set for higher open as Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts USNA Hot Sheet
Join SI Premium – FREE
USANA Health Sciences (NYSE: USNA) reported Q3 EPS of ($0.15), $0.71 worse than the analyst estimate of $0.56. Revenue for the quarter came in at $214 million versus the consensus estimate of $224.97 million.
GUIDANCE:
USANA Health Sciences sees FY2025 EPS of $0.78, versus the consensus of $1.70. USANA Health Sciences sees FY2025 revenue of $920 million, versus the consensus of $919.6 million.
For earnings history and earnings-related data on USANA Health Sciences (USNA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Uber Q3 profit, revenue beat estimates as gross bookings jump 20%
- L.B. Foster (FSTR) Reports In-Line Q3 EPS ; Offers Guidance
- CS Disco, Inc (LAW) Misses Q3 EPS by 6c; offers guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
